AJP - Heart Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 284: H385-H392, 2003. First published September 19, 2002; doi:10.1152/ajpheart.00658.2002
0363-6135/03 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
284/1/H385    most recent
00658.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (13)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Teeters, J. C.
Right arrow Articles by Faber, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Teeters, J. C.
Right arrow Articles by Faber, J. E.
Vol. 284, Issue 1, H385-H392, January 2003

Systemic alpha 1A-adrenoceptor antagonist inhibits neointimal growth after balloon injury of rat carotid artery

John C. Teeters*, Cauveh Erami*, Hua Zhang, and James E. Faber

Department of Cell and Molecular Physiology, University of North Carolina, Chapel Hill, North Carolina, 27599-7545

Previous in vitro and in vivo studies have shown that norepinephrine, acting through alpha 1A-adrenoceptors, stimulates hypertrophy, proliferation, and migration of vascular smooth muscle cells and adventitial fibroblasts and may contribute to neointimal growth, lumen loss, and inward remodeling caused by iatrogenic wall injury and vascular disease. Our present aim was to determine whether intravenous administration of the alpha 1A-adrenoceptor antagonist KMD-3213, at dosages without systemic hemodynamic effects, inhibits wall growth after injury. Inhibition of alpha 1A-adrenoceptors with 12.8 and 32 µg/kg KMD-3213 had no effect on arterial pressure or renal and hindquarter resistances in anesthetized rats. A second group then received carotid balloon injury and continuous intravenous KMD-3213 at 4 and 10 µg · kg-1 · h-1 for 2 wk. Mean, systolic, and diastolic arterial pressures and heart rate of conscious unrestrained rats were unaffected. KMD-3213 reduced neointima growth by ~30 and 46% at the two doses (P < 0.01). These data support the novel hypothesis that a direct alpha 1A-adrenoceptor-dependent trophic action of catecholamines is augmented by injury and may contribute significantly to hypertrophic vascular disease.

adrenergic receptor; smooth muscle cell

* J. C. Teeters and C. Erami contributed equally to this work.




This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
M. C. Vinci, L. Bellik, S. Filippi, F. Ledda, and A. Parenti
Trophic effects induced by {alpha}1D-adrenoceptors on endothelial cells are potentiated by hypoxia
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2140 - H2147.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
C. Hosoda, M. Hiroyama, A. Sanbe, J.-i. Birumachi, T. Kitamura, S. Cotecchia, P. C. Simpson, G. Tsujimoto, and A. Tanoue
Blockade of both {alpha}1A- and {alpha}1B-adrenergic receptor subtype signaling is required to inhibit neointimal formation in the mouse femoral artery
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H514 - H519.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
J. E. Faber, C. L. Szymeczek, S. S. Salvi, and H. Zhang
Enhanced {alpha}1-adrenergic trophic activity in pulmonary artery of hypoxic pulmonary hypertensive rats
Am J Physiol Heart Circ Physiol, November 1, 2006; 291(5): H2272 - H2281.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
C. Erami, H. Zhang, A. Tanoue, G. Tsujimoto, S. A. Thomas, and J. E. Faber
Adrenergic catecholamine trophic activity contributes to flow-mediated arterial remodeling
Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H744 - H753.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
D. Chalothorn, H. Zhang, J. A. Clayton, S. A. Thomas, and J. E. Faber
Catecholamines augment collateral vessel growth and angiogenesis in hindlimb ischemia
Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H947 - H959.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
H. Zhang, D. Chalothorn, L. F. Jackson, D. C. Lee, and J. E. Faber
Transactivation of Epidermal Growth Factor Receptor Mediates Catecholamine-Induced Growth of Vascular Smooth Muscle
Circ. Res., November 12, 2004; 95(10): 989 - 997.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
H. Zhang, S. Cotecchia, S. A. Thomas, A. Tanoue, G. Tsujimoto, and J. E. Faber
Gene deletion of dopamine {beta}-hydroxylase and {alpha}1-adrenoceptors demonstrates involvement of catecholamines in vascular remodeling
Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H2106 - H2114.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
T. Bleeke, H. Zhang, N. Madamanchi, C. Patterson, and J. E. Faber
Catecholamine-Induced Vascular Wall Growth Is Dependent on Generation of Reactive Oxygen Species
Circ. Res., January 9, 2004; 94(1): 37 - 45.
[Abstract] [Full Text] [PDF]

Home page
 Arterioscler. Thromb. Vasc. Bio.Home page
L. Li, E. W. Lee, H. Ji, and Z. Zukowska
Neuropeptide Y-Induced Acceleration of Postangioplasty Occlusion of Rat Carotid Artery
Arterioscler Thromb Vasc Biol, July 1, 2003; 23(7): 1204 - 1210.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online